Tenax Therapeutics (TENX) Treasury Shares (2012 - 2025)
Tenax Therapeutics recorded quarterly Treasury Shares of $16.7 million in Q4 2025, little changed quarter-over-quarter from $16.7 million in Q3 2025, and little changed year-over-year from $16.7 million in Q4 2024.
Tenax Therapeutics' Treasury Shares history runs 10 years deep, the most recent figure standing at $16.7 million for Q4 2025.
- In Q4 2025, Treasury Shares changed 0.0% year-over-year to $16.7 million; the TTM figure through Dec 2025 stood at $16.7 million (changed 0.0% YoY), while the FY2025 annual figure was $16.7 million, changed 0.0% from the prior year.
- Treasury Shares came in at $16.7 million for Q4 2025 at Tenax Therapeutics, roughly flat from $16.7 million in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $17.3 million in Q1 2023 to a low of $216667.0 in Q4 2023.
- A 3-year average of $11.8 million and a median of $16.7 million in 2024 frame the typical range for Treasury Shares.
- On a YoY basis, Treasury Shares climbed as much as 7592.3% in 2024 and fell as far as 98.75% in 2024.
- Tenax Therapeutics' Treasury Shares stood at $216667.0 in 2023, then jumped by 7592.3% to $16.7 million in 2024, then changed by 0.0% to $16.7 million in 2025.
- According to Business Quant data, Treasury Shares over the past three periods registered $16.7 million, $16.7 million, and $16.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.67 Mn |
| Dec 31, 2025 | 16.67 Mn |
| Sep 30, 2025 | 16.67 Mn |
| Sep 30, 2025 | 16.67 Mn |
| Jun 30, 2025 | 16.67 Mn |
| Jun 30, 2025 | 16.67 Mn |
| Mar 31, 2025 | 16.67 Mn |
| Mar 31, 2025 | 16.67 Mn |
| Dec 31, 2024 | 16.67 Mn |
| Dec 31, 2024 | 16.67 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 3.20 Mn |
| Mar 31, 2024 | 216,667.00 |
| Mar 31, 2024 | 216,667.00 |
| Dec 31, 2023 | 216,667.00 |
| Dec 31, 2023 | 216,667.00 |
| Sep 30, 2023 | 17.33 Mn |
| Sep 30, 2023 | 17.33 Mn |
| Jun 30, 2023 | 17.33 Mn |
| Jun 30, 2023 | 17.33 Mn |
| Mar 31, 2023 | 17.33 Mn |
| Mar 31, 2023 | 17.33 Mn |
| Dec 31, 2018 | 19,914.00 |
| Dec 31, 2018 | 19,914.00 |
| Sep 30, 2018 | 19,914.00 |
| Sep 30, 2018 | 19,914.00 |
| Jun 30, 2018 | 39,828.00 |
| Jun 30, 2018 | 39,828.00 |
| Mar 31, 2017 | 106.00 |
| Mar 31, 2017 | 106.00 |
| Dec 31, 2016 | 12.00 |
| Dec 31, 2016 | 12.00 |
| Sep 30, 2016 | 367.00 |
| Sep 30, 2016 | 367.00 |
| Jun 30, 2016 | 520.00 |
| Jun 30, 2016 | 520.00 |
| Mar 31, 2016 | 241.00 |
| Mar 31, 2016 | 241.00 |
| Dec 31, 2015 | 20.00 |
| Dec 31, 2015 | 20.00 |
| Apr 30, 2015 | 90.00 |
| Apr 30, 2015 | 90.00 |
| Jan 31, 2015 | 256.00 |
| Jan 31, 2015 | 256.00 |
| Oct 31, 2014 | 229.00 |
| Oct 31, 2014 | 229.00 |
| Jul 31, 2014 | 12,384.00 |
| Jul 31, 2014 | 12,384.00 |
| Apr 30, 2014 | 42,478.00 |
| Apr 30, 2014 | 42,478.00 |
| Jan 31, 2014 | 42,629.00 |
| Jan 31, 2014 | 42,629.00 |
| Oct 31, 2013 | 10,639.00 |
| Oct 31, 2013 | 10,639.00 |
| Jul 31, 2013 | 13,975.00 |
| Jul 31, 2013 | 13,975.00 |
| Apr 30, 2013 | 1,917.00 |
| Apr 30, 2013 | 1,917.00 |
| Jan 31, 2013 | 55,537.00 |
| Jan 31, 2013 | 55,537.00 |
| Oct 31, 2012 | 75,672.00 |
| Oct 31, 2012 | 75,672.00 |
| Jul 31, 2012 | 123,868.00 |
| Jul 31, 2012 | 123,868.00 |
| Apr 30, 2012 | 1,805.00 |
| Apr 30, 2012 | 1,805.00 |